Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level

References

• Guariguata L, DR W, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment. J Neurol. 2005;253(4):477–482. doi:10.1007/s00415-005-0036-4
   PubMedGoogle Scholar
• Mehla J, Chauhan BC, Chauhan NB. Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis. 2014;39(1):145–162. doi:10.3233/JAD-131238
   PubMedGoogle Scholar
• Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol. 2012;32(9):2060–2067. doi:10.1161/ATVBAHA.112.252759
   PubMed Web of Science ®Google Scholar
• McEwen BS, Magarin ̃os AḾ, Reagan LP. Studies of hormone action in the hippocampal formation possible relevance to depression and diabetes. J Psychosom Res. 2002;53:883–890. doi:10.1016/S0022-3999(02)00307-0
   PubMed Web of Science ®Google Scholar
• Zhen YF, Zhang J, Liu XY, et al. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology. 2012;227(1):93–100. doi:10.1007/s00213-012-2942-3
   PubMedGoogle Scholar
• Yang Y, Fang H, Xu G, et al. Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats. Mol Med Rep. 2018;18:2449–2457.
   PubMed Web of Science ®Google Scholar
• Fang H, Xu X-Y, Xu R-Z, Zhen YF, Xu G, Y-k L. Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes. J Diabetes Complications. 2018;32(1):56–60. doi:10.1016/j.jdiacomp.2017.09.004
   PubMedGoogle Scholar
• Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2(3):246–255. doi:10.1016/S2213-8587(13)70088-3
   PubMed Web of Science ®Google Scholar
• Swomley AM, Butterfield DA. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics. Arch Toxicol. 2015;89(10):1669–1680. doi:10.1007/s00204-015-1556-z
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003;23(22):8137–8151. doi:10.1128/MCB.23.22.8137-8151.2003
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Papageorgiou N, Androulakis E, et al. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol. 2013;62(8):667–676. doi:10.1016/j.jacc.2013.03.089
   PubMed Web of Science ®Google Scholar
• Tapias V, Jainuddin S, Ahuja M, et al. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. Hum Mol Genet. 2018;27(16):2874–2892. doi:10.1093/hmg/ddy201
   PubMed Web of Science ®Google Scholar
• Yang Y, Fan C, Wang B, et al. Pterostilbene attenuates high glucose-induced oxidative injury in hippocampal neuronal cells by activating nuclear factor erythroid 2-related factor 2. BBA Mol Basis Dis. 2017;1863(4):827–837. doi:10.1016/j.bbadis.2017.01.005
   PubMedGoogle Scholar
• Hosakote YM, Jantzi PD, Esham DL, et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2011;183(11):1550–1560. doi:10.1164/rccm.201010-1755OC
   PubMed Web of Science ®Google Scholar
• Chen M-L, Yi L, Jin X, et al. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy. 2014;9(12):2033–2045. doi:10.4161/auto.26336
   Google Scholar
• Zeng K, Wang Y, Yang N, et al. Resveratrol inhibits diabetic-induced muller cells apoptosis through microRNA-29b/specificity protein 1 pathway. Mol Neurobiol. 2017;54(6):4000–4014. doi:10.1007/s12035-016-9972-5
   PubMed Web of Science ®Google Scholar
• Lee SM, Yang H, Tartar DM, et al. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia. 2011;54(5):1136–1146. doi:10.1007/s00125-011-2064-1
   PubMed Web of Science ®Google Scholar
• Jimenez-Gomez Y, Mattison JA, Pearson KJ, et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab. 2013;18(4):533–545. doi:10.1016/j.cmet.2013.09.004
   PubMed Web of Science ®Google Scholar
• Khazaei M, Karimi J, Sheikh N, et al. Effects of resveratrol on receptor for advanced glycation end products (rage) expression and oxidative stress in the liver of rats with type 2 diabetes. Phytother Res. 2016;30(1):66–71. doi:10.1002/ptr.5501
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim YS, Kang SS, Cho GJ, Choi WS. Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina. Diabetes. 2010;59(7):1825–1835. doi:10.2337/db09-1431
   PubMed Web of Science ®Google Scholar
• Ma X, Sun Z, Liu Y, Jia Y, Zhang B, Zhang J. Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen Res. 2013;8(22):2050–2059. doi:10.3969/j.issn.1673-5374.2013.22.004
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–2251. doi:10.1016/S0140-6736(17)30058-2
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–1382. doi:10.1124/dmd.104.000885
   PubMed Web of Science ®Google Scholar
• Wenzel E, Soldo T, Erbersdobler H, Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Nutr Food Res. 2005;49:482–494. doi:10.1002/mnfr.200500003
   Google Scholar
• Wang G, Song X, Zhao L, Li Z, Liu B. Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity. Biomed Res Int. 2018;2018:2150218.
   PubMedGoogle Scholar
• Zhao Y, Song W, Wang Z, et al. Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation. Redox Biol. 2018;14:609–617. doi:10.1016/j.redox.2017.11.007
   PubMed Web of Science ®Google Scholar
• Boocock DJ, Faust GES, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246–1252. doi:10.1158/1055-9965.EPI-07-0022
   PubMed Web of Science ®Google Scholar
• Morris RG, Garrud P, Rawlins J, O’Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982;297(5868):681. doi:10.1038/297681a0
   PubMed Web of Science ®Google Scholar
• Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88(Pt B):314–336. doi:10.1016/j.freeradbiomed.2015.05.036
   PubMedGoogle Scholar
• Vanessa Fiorentino T, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695–5703. doi:10.2174/1381612811319320005
   PubMed Web of Science ®Google Scholar
• Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal. 2016;25(12):657–684. doi:10.1089/ars.2016.6664
   PubMed Web of Science ®Google Scholar
• Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473(24):4527–4550. doi:10.1042/BCJ20160503C
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813. doi:10.1038/414813a
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002;288(20):2579–2588. doi:10.1001/jama.288.20.2579
   PubMed Web of Science ®Google Scholar
• Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15(10):7266–7291. doi:10.3390/molecules15107266
   PubMed Web of Science ®Google Scholar
• de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013;369(26):2492–2503. doi:10.1056/NEJMoa1306033
   PubMed Web of Science ®Google Scholar
• Banerjee B, Nandi P, Chakraborty S, Raha S, Sen PC, Jana K. Resveratrol ameliorates benzo(a)pyrene-induced testicular dysfunction and apoptosis: involvement of p38 MAPK/ATF2/iNOS signaling. J Nutr Biochem. 2016;34:17–29. doi:10.1016/j.jnutbio.2016.04.003
   PubMed Web of Science ®Google Scholar
• González-Rodríguez Á, Santamaría B, Mas-Gutierrez JA, et al. Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. Mol Nutr Food Res. 2015;59(8):1431–1442. doi:10.1002/mnfr.201400933
   PubMed Web of Science ®Google Scholar
• Schmatz R, Mazzanti CM, Spanevello R, et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2009;610(1–3):42–48. doi:10.1016/j.ejphar.2009.03.032
   PubMed Web of Science ®Google Scholar
• Gocmez SS, Şahin TD, Yazir Y, et al. Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia. Physiol Behav. 2019;201:198–207. doi:10.1016/j.physbeh.2018.12.012
   PubMed Web of Science ®Google Scholar
• Bai Y, Cui W, Xin Y, et al. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J Mol Cell Cardiol. 2013;57:82–95. doi:10.1016/j.yjmcc.2013.01.008
   PubMed Web of Science ®Google Scholar
• Tan Y, Ichikawa T, Li J, et al. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress–induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 2011;60(2):625–633. doi:10.2337/db10-1164
   PubMed Web of Science ®Google Scholar
• Corenblum MJ, Ray S, Remley QW, et al. Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle-age period. Aging Cell. 2016;15(4):725–736. doi:10.1111/acel.12482
   PubMedGoogle Scholar
• Luo ZF, Qi W, Feng B, et al. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Life Sci. 2011;88(11–12):512–520. doi:10.1016/j.lfs.2010.12.023
   PubMed Web of Science ®Google Scholar